Bayer CropScience declares final dividend of Rs 60 per share

Bayer CropScience Limited has declared a final dividend of ₹60 per equity share for the financial year 2025-26. The company has fixed August 5, 2026, as the record date to determine shareholder eligibility for the payout. The dividend is subject to the approval of shareholders at the upcoming Annual General Meeting.

The Board of Directors approved the dividend at a meeting held on May 26, 2026. The payout will be made to shareholders whose names appear in the Register of Members as on the record date. The company has also detailed the tax deduction at source (TDS) implications for the dividend distribution under the Income Tax Act, 2025.

Tax Deduction and Compliance

The company will deduct tax at source from the dividend paid to shareholders. For resident shareholders, the TDS rate is 10% if a valid Permanent Account Number (PAN) is registered. If PAN is not registered or is invalid, the TDS rate increases to 20%. No tax will be deducted if the total dividend received during FY 2026-27 does not exceed ₹10,000 or if a valid Form 121 is submitted.

Non-resident shareholders are subject to a withholding tax rate of 20% plus applicable surcharge and cess. However, they may opt for beneficial rates under Double Tax Avoidance Agreements (DTAA) by submitting necessary documents, including a Tax Residency Certificate and a self-declaration in Form 41.

Key AGM and Dividend Details

Event	Details
Record Date	August 5, 2026
Book Closure	August 6, 2026 to August 13, 2026
Meeting Date	August 19, 2026
Dividend Amount	₹60 per equity share
Financial Year	2025-26
Paid up Value	₹10 per share

Shareholders must ensure their PAN, residential status, and bank details are updated with their depository participant or the company's registrar by the record date to ensure correct TDS deduction.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.65%	-1.04%	-8.10%	-8.53%	-34.67%	-27.37%

Bayer AG has agreed to acquire up to 53,54,030 equity shares from Bayer CropScience AG, representing 11.91% of the paid-up equity share capital of Bayer CropScience Limited . The inter-se transfer between two promoters will be executed through the block deal mechanism on or after July 8, 2026. The transaction is exempt from the requirement to make an open offer under Regulation 10(1)(a)(ii) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The acquisition price will not exceed the limits provided in the proviso to Regulation 10(1)(a) of the Takeover Regulations. The volume weighted average market price for the 60 trading days preceding the notice was INR 4,434 per share. Bayer AG confirmed that the acquisition price would not be higher by more than 25% of this computed price.

Shareholding Pattern

Following the transaction, Bayer AG's shareholding will increase from 8.43% to 20.34%. Bayer CropScience AG will cease to hold shares in the target company, reducing its stake from 11.91% to 0%. The total promoter group shareholding, including Persons Acting in Concert (PACs), remains at 71.43%.

Promoter / PAC	Shares Before Transaction	% Before Transaction	Shares After Transaction	% After Transaction
Bayer AG	37,88,433	8.43	91,42,463	20.34
Bayer Vapi Private Limited	80,39,736	17.89	80,39,736	17.89
Bayer Investments India Private Limited	67,58,082	15.04	67,58,082	15.04
Bayer SAS	66,18,105	14.73	66,18,105	14.73
Monsanto Company	15,44,613	3.44	15,44,613	3.44
Bayer CropScience AG (Seller)	53,54,030	11.91	0	0

Regulatory Disclosures

Bayer AG and Bayer CropScience AG have confirmed compliance with applicable disclosure requirements in Chapter V of the Takeover Regulations. The acquirer declared that all conditions specified under Regulation 10(1)(a)(ii) regarding the exemption have been duly complied with. The disclosures were signed by authorized signatories Markus Goblet and Dr. Sven Vorstius on July 1, 2026.